EUCRATES BIOMEDICAL ACQU COR - SHS (EUCR)

CUSIP: G3141W106

Q3 2021 13F Holders as of 30 Sep 2021

Type / Class
Equity / SHS
Total 13F shares
5,118,549
Share change
+255,526
Total reported value
$50,060,000
Price per share
$9.78
Number of holders
34
Value change
+$2,492,821
Number of buys
13
Number of sells
8

Quarterly Holders Quick Answers

What is CUSIP G3141W106?
CUSIP G3141W106 identifies EUCR - EUCRATES BIOMEDICAL ACQU COR - SHS in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of EUCRATES BIOMEDICAL ACQU COR - SHS (EUCR) as of Q3 2021

As of 30 Sep 2021, EUCRATES BIOMEDICAL ACQU COR - SHS (EUCR) was held by 34 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 5,118,549 shares. The largest 10 holders included BlackRock Inc., 683 Capital Management, LLC, Hudson Bay Capital Management LP, Altium Capital Management LP, CVI Holdings, LLC, SPHERA FUNDS MANAGEMENT LTD., KINGDON CAPITAL MANAGEMENT, L.L.C., EcoR1 Capital, LLC, D. E. Shaw & Co., Inc., and First Trust Capital Management L.P.. This page lists 34 institutional shareholders reporting positions in this security for the Q3 2021 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.